LUCINTEL FORECASTS THE GLOBAL MONTELUKAST API MARKET IS EXPECTED TO GROW WITH A CAGR OF 11.8% FROM 2024 TO 2030

Lucintel Forecasts the Global Montelukast Api Market is expected to grow with a CAGR of 11.8% from 2024 to 2030

Lucintel Forecasts the Global Montelukast Api Market is expected to grow with a CAGR of 11.8% from 2024 to 2030

Blog Article

According to a market report by Lucintel, the future of the global montelukast API market looks promising with opportunities in the asthma, allergic rhinitis, urticaria, and bronchospasm markets. The global montelukast API market is expected to grow with a CAGR of 11.8% from 2024 to 2030. The major drivers for this market are higher incidence of asthma and allergic rhinitis and surge in aging population.

A more than 150 – page report is developed to understand Trends, opportunity and forecast in montelukast API market to 2030 by type (tablet, chewable tablet, and oral solution), application (asthma, allergic rhinitis, urticaria, bronchospasm, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).

In this market, tablet, chewable tablet, and oral solution are the major segments of montelukast API market by type. Lucintel forecasts that tablet will remain the largest segment over the forecast period due to ease of swallowing and dosage control.

Within this market, asthma will remain the largest segment due to rising prevalence and potential treatment benefits.

Download sample by clicking on montelukast API market

North America will remain the largest region over the forecast period due to high prevalence of asthma and allergic rhinitis in the aging population.

Merck, Cipla, Morepen Laboratories, Sun Pharma, Teva Pharmaceutical Industries, Intas Pharmaceuticals, Apotex, Sanyo Chemical Industries, Mylan, and Delmar Chemicals are the major suppliers in the montelukast API market.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected]

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.

Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1 972.636.5056

Explore Our Latest Publications

Non-Metallurgical Alumina Market in Canada

Polished Concrete Market in Canada

Porous Ceramic Market in Canada

Synthetic Diamond Market in Canada

Pyroxenite Market in Canada

Rapid Self-Healing Gel Market in Canada

 

 

 

 

Report this page